(Q44233609)

1 December 2017

title

Ertapenem (MK-0826), a new carbapenem: comparative in vitro activity against clinically significant anaerobes (English)

1 reference

1 December 2017

main subject

carbapenem antibiotic

0 references

author name string

Kenneth E Aldridge

series ordinal

1

1 reference

1 December 2017

publication date

1 October 2002

1 reference

Diagnostic Microbiology and Infectious Disease

1 December 2017

published in

1 reference

1 December 2017

volume

44

1 reference

1 December 2017

issue

2

1 reference

1 December 2017

page(s)

181-186

1 reference

Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900430-3

7 January 2021

A five-year multicenter study of the susceptibility of the Bacteroides fragilis group isolates to cephalosporins, cephamins, penicillins, clindamycin, and metronidazole in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900430-3

7 January 2021

Comparison of in vitro antibiograms of Bacteroides fragilis group isolates: differences in resistance rates in two institutions because of differences in susceptibility testing methodology

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900430-3

7 January 2021

In vitro activities of MK-0826 and 16 other antimicrobials against Bacteroides fragilis group strains

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900430-3

7 January 2021

In-vitro antimicrobial activity of a carbapenem, MK-0826 (L-749,345) and provisional interpretive criteria for disc tests

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900430-3

7 January 2021

In vitro activities of ertapenem (MK-0826) against clinical bacterial isolates from 11 North American medical centers

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900430-3

7 January 2021

Comparative In vitro activities of ertapenem (MK-0826) against 1,001 anaerobes isolated from human intra-abdominal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900430-3

7 January 2021

National hospital survey of anaerobic culture and susceptibility testing methods: results and recommendations for improvement

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900430-3

7 January 2021

In vitro activities of the potent, broad-spectrum carbapenem MK-0826 (L-749,345) against broad-spectrum beta-lactamase-and extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli clinical isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900430-3

7 January 2021

Antimicrobial resistance and clinical outcome of Bacteroides bacteremia: findings of a multicenter prospective observational trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900430-3

7 January 2021

High prevalence of resistance to clindamycin in Bacteroides fragilis group isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900430-3

7 January 2021

Attributable mortality of bacteremia associated with the Bacteroides fragilis group

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900430-3

7 January 2021

Bacteroides species highly resistant to metronidazole: an emerging clinical problem?

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900430-3

7 January 2021

Subdural empyema caused by Prevotella loescheii with reduced susceptibility to metronidazole

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900430-3

7 January 2021

Plasmid-mediated, transferable resistance to clindamycin and erythromycin in Bacteroides fragilis

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900430-3

7 January 2021

In vitro activities of MK-826 (L-749,345) against 363 strains of anaerobic bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900430-3

7 January 2021

10.1016/S0732-8893(02)00430-3

Identifiers

DOI

1 reference

1 December 2017

1 reference